Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 6/20 | 0.34 |
| ▸ | MMP13 | P45452 | 6/20 | 0.34 |
| ▸ | MMP9 | P14780 | 5/20 | 0.34 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.33 |
| ▸ | CXCR3 | P49682 | 1/20 | 0.32 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 1/20 | 0.30 |
| ▸ | MMP3 | P08254 | 1/20 | 0.30 |
| ▸ | MMP7 | P09237 | 1/20 | 0.30 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5773054 | 0.99 | MMP1 (0.34) | MMP1MMP13MMP9KCNA5CXCR3 | |
| SCHEMBL1602201 | 0.77 | HTT (0.33) | MMP1MMP13MMP9KCNA5CHRM5 | |
| SCHEMBL1600557 | 0.76 | HTT (0.32) | MMP1MMP13MMP9KCNA5CHRM5 | |
| SCHEMBL1600558 | 0.73 | MLNR (0.39) | — | |
| SCHEMBL1602198 | 0.68 | MLNR (0.41) | MMP1MMP13MMP9 | |
| SCHEMBL1600555 | 0.68 | MLNR (0.41) | — | |
| SCHEMBL1600561 | 0.67 | HTT (0.36) | MMP1MMP13MMP9MMP2MMP3 | |
| SCHEMBL12709235 | 0.67 | MLNR (0.61) | — | |
| SCHEMBL1601533 | 0.65 | MMP1 (0.37) | MMP1MMP13MMP9KCNA5CXCR3 | |
| SCHEMBL1602560 | 0.65 | MMP1 (0.36) | MMP1MMP13MMP9KCNA5CXCR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1637518-A2 | Inhibitors of aspartyl protease | Vertex Pharmaceuticals Incorporated (US) | 2006-03-22 | — | — | EP | disclosed |